Juan Francisco Grau-Bejar

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityPredictive and prognostic markersBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
Platinum Rechallenge in Platinum-Resistant Ovarian Cancer: Clinical Outcomes and the Impact of BRCA Status.

|Mar 16, 2026
Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer.

Juan Francisco Grau Béjar, Elisa Yaniz Galende, Catherine Genestie

|Jul 02, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer.

Juan Francisco Grau Bejar, Elisa Yaniz Galende, Qinghe Zeng

|Apr 26, 2024
Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy.

Elisa Yaniz-Galende, Qinghe Zeng, Juan F Bejar-Grau

|Jan 02, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer.

Ana Oaknin, Sharad A Ghamande, Yuka Kasamatsu

Pageof 1

Frequent Collaborators

2 joint publications

Ana Oaknin

1 joint publications

Elisa Yaniz-Galende

1 joint publications

Qinghe Zeng

1 joint publications

Christophe Klein